DK1027895T3 - Erysipelothrix rhusiopathiae-antigener og vaccinepræparater - Google Patents

Erysipelothrix rhusiopathiae-antigener og vaccinepræparater

Info

Publication number
DK1027895T3
DK1027895T3 DK99309202T DK99309202T DK1027895T3 DK 1027895 T3 DK1027895 T3 DK 1027895T3 DK 99309202 T DK99309202 T DK 99309202T DK 99309202 T DK99309202 T DK 99309202T DK 1027895 T3 DK1027895 T3 DK 1027895T3
Authority
DK
Denmark
Prior art keywords
vaccine preparations
erysipelothrix rhusiopathiae
antigens
rhusiopathiae antigens
erysipelothrix
Prior art date
Application number
DK99309202T
Other languages
English (en)
Inventor
David Stewart Roberts
Brian Thomas Suiter
Leroy Allen Swearingin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1027895T3 publication Critical patent/DK1027895T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK99309202T 1999-01-29 1999-11-18 Erysipelothrix rhusiopathiae-antigener og vaccinepræparater DK1027895T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11770499P 1999-01-29 1999-01-29

Publications (1)

Publication Number Publication Date
DK1027895T3 true DK1027895T3 (da) 2008-06-09

Family

ID=22374369

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99309202T DK1027895T3 (da) 1999-01-29 1999-11-18 Erysipelothrix rhusiopathiae-antigener og vaccinepræparater

Country Status (16)

Country Link
EP (1) EP1027895B1 (da)
JP (3) JP3535436B2 (da)
CN (1) CN1210062C (da)
AR (1) AR020022A1 (da)
AT (1) ATE386540T1 (da)
AU (1) AU776847B2 (da)
BR (1) BR9905853B1 (da)
CA (1) CA2290078C (da)
CY (1) CY1107910T1 (da)
DE (1) DE69938168T2 (da)
DK (1) DK1027895T3 (da)
ES (1) ES2301230T3 (da)
NZ (1) NZ501128A (da)
PT (1) PT1027895E (da)
TW (1) TW546146B (da)
ZA (1) ZA997138B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
CN107496913A (zh) * 2017-09-15 2017-12-22 天津瑞普生物技术股份有限公司 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法
CN107648599A (zh) * 2017-09-18 2018-02-02 天津瑞普生物技术股份有限公司 一种猪丹毒、猪细小病毒二联灭活疫苗的制备方法
CN110812473A (zh) * 2019-12-10 2020-02-21 广东君睿生物技术研究有限公司 一种副猪嗜血杆菌病、猪链球菌病和猪多杀性巴氏杆菌病三联灭活疫苗及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
US5695769A (en) * 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
DK0669971T3 (da) * 1991-11-15 2003-04-22 Pfizer Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
JP3072345B1 (ja) * 1999-03-31 2000-07-31 農林水産省家畜衛生試験場長 豚丹毒菌の組換えサブユニットワクチン

Also Published As

Publication number Publication date
CN1210062C (zh) 2005-07-13
JP2003160507A (ja) 2003-06-03
EP1027895A3 (en) 2001-07-18
AU776847B2 (en) 2004-09-23
JP2000219637A (ja) 2000-08-08
PT1027895E (pt) 2008-03-18
BR9905853B1 (pt) 2011-11-01
JP4714167B2 (ja) 2011-06-29
DE69938168D1 (de) 2008-04-03
NZ501128A (en) 2001-12-21
BR9905853A (pt) 2000-11-14
JP2007119499A (ja) 2007-05-17
CA2290078C (en) 2013-01-22
DE69938168T2 (de) 2009-02-26
ZA997138B (en) 2001-05-16
EP1027895B1 (en) 2008-02-20
AR020022A1 (es) 2002-03-27
ES2301230T3 (es) 2008-06-16
CY1107910T1 (el) 2013-09-04
HK1029062A1 (en) 2001-03-23
CA2290078A1 (en) 2000-07-29
AU5944599A (en) 2000-08-03
CN1262129A (zh) 2000-08-09
EP1027895A2 (en) 2000-08-16
TW546146B (en) 2003-08-11
ATE386540T1 (de) 2008-03-15
JP3535436B2 (ja) 2004-06-07

Similar Documents

Publication Publication Date Title
FR2775601B1 (fr) Vaccins vivants recombines et adjuves
DK1210113T3 (da) Kombinerede vaccinepræparater
NL300311I2 (nl) Adjuvanssytemen en vaccins
CY2009014I2 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
DK0894135T3 (da) Multivalent og multispecifikt antigenbindingsprotein
NO20015888L (no) Implanterbart gelpreparat og fremgangsmåter for fremstilling derav
ATE345392T1 (de) Genetisch manipulierter bleb impfstoff
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
NO20032303D0 (no) Frysetörket pantoprazol-preparat og pantoprazol-injeksjon
DK2325317T3 (da) Receptornukleinsyrer og polypeptidr
DK1228217T3 (da) Konserverede neisseria-antigener
BR9711853A (pt) Vacinas
MA25489A1 (fr) Vaccins
EP1242049A4 (en) VACCINE COMPOSITIONS AND ANTIGEN PEPTIDES ASSOCIATED WITH CLASS I HLA-A2 TUMOR
DK1210112T3 (da) Vaccine mod HBV og HPV
DE60002650D1 (de) Öladjuvierter Impfstoff
NO2006005I2 (no) Difteri-,tetanus-, acellulære kikhoste- og polioantigener
EP1185545A4 (en) CD4-INDEPENDENT HIV ENVELOPE PROTEINS FOR USE AS VACCINES AND THERAPEUTIC AGENTS
AU5577201A (en) Immunogenic pneumococcal protein and vaccine compositions thereof
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
DK1027895T3 (da) Erysipelothrix rhusiopathiae-antigener og vaccinepræparater
ATE519775T1 (de) Rekombinante untereinheiten-impfstoffe
EP1283717A4 (en) RECOMBINANT LEUKOTOXIN VACCINE FROM FUSOBACTERIUM NECROPHORUM AND ITS PREPARATION
DK1216021T3 (da) Farmaceutiske og/eller kosmetiske præparater
FR2802775B1 (fr) Preparations glacees et aerees